Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women
Objective: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders that is associated with different metabolic, reproductive and psychological consequences. The main aim of this study was to compare the sexual function and quality of life in women with polycystic ovary syndrome and healthy women.
Materials and methods: This is a causal-comparative study in which 129 women with polycystic ovary syndrome were qualified as the research group. The control group consisted of 125 healthy women. The sampling method was convenient and was done using Rotterdam criteria. Women of both research and control groups responded to the FSFI and WHOQOL-BREF questionnaires. Data were analyzed with SPSS software using MANOVA.
Results: According to findings, all of quality of life subscales except environment domain were significantly lower in research group than healthy group (p < 0.01), but none of sexual function subscales were significantly different between two groups (p > 0.05).
Conclusion: Women with PCOS in term of some quality of life parameters have lower performance than healthy women. Therefore, it seems to be essential to increase awareness about symptoms and psychological consequences and referring process in order to take advantage of the advisory services.
2. Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod 2006;21:1925-34.
3. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011;195: S65-112.
4. Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS. Cardiovascular risk in women with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001; 28:111-33.
5. Legro RS. Polycystic ovary syndrome. Long term sequelae and management. Minerva Ginecol 2002; 54:97-114.
6. Eggers S, Kirchengast S. The polycystic ovary syndrome—a medical condition but also an important psychosocial problem. Coll Antropol 2001; 25:673-85.
7. Moran LJ, Deeks AA, Gibson-Helm ME, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovarysyndrome. Hum Reprod 2012; 27: 2082-8.
8. Orio F, Vuolo L, Palomba S, Lombardi G, Colao A. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 2008; 60: 39-51.
9. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv 2006;61 :723-32.
10. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-93.
11. Masters WH, Johnson VJ. Human sexual response. New York: Bantam Books; 1986.
12. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005; 153: 853-60.
13. Dobkin RD, Leiblum SR, Rosen RC, Menza M, Marin H. Depression and sexual functioning in minority women: current status and future directions. J Sex Marital Ther 2006; 32:23-36.
14. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, et al. Revised definitions of women's sexual dysfunction. J Sex Med 2004; 1:40-8.
15. Mansson M, Norstrom K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landen M. Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol 2011; 155:161-5.
16. Stovall DW, Scriver JL, Clayton AH, Williams CD, Pastore LM. Sexual function in women with polycystic ovary syndrome. J Sex Med 2012; 9: 224-30.
17. Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R, et al. Association of body weight with sexual function in women. Int J Impot Res 2007; 19: 353-7.
18. Trent ME, Rich M, Austin SB, Gordon CM. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003; 16: 33-7.
19. Ferraresi SR, Lara LA, Reis RM, Rosa e Silva AC. Changes in sexual function among women with polycystic ovary syndrome: a pilot study. J Sex Med 2013;10 :467-73.
20. Stovall DW, Scriver JL, Clayton AH, Williams CD, Pastore LM. Sexual function in women with polycystic ovary syndrome. J Sex Med 2012;9 :224-30.
21. Månsson M, Norström K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landén M. Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol 2011;155:161-5.
22. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M,et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;153:853-60.
23. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 2006; 22:80-6.
24. Drosdzol A, Skrzypulec V, Mazur B, Pawlińska-Chmara R. Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome. Folia Histochem Cytobiol 2007; 45 Suppl 1:S93-7.
25. Lemieux J, Goodwin PJ, Bordeleau LJ, Lauzier S, Théberge V. Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001–2009). J Natl Cancer Inst 2011;103:178-231.
26. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28 : 551–8.
27. Morrow AM, Quine S, Loughlin EV, Craig JC. Different priorities: a comparison of parents’ and health professionals’ perceptions of quality of life in quadriplegic cerebral palsy. Arch Dis Child 2008;93:119-25.
28. Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality of life,psychosocial well-being and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88:5801-7.
29. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf) 2007;66:373-9.
30. Mason H, Colao A, Blume Peytavi U, Rice S, Qureshi A, Pellatt L, et al. Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review. Clin Endocrinol (Oxf) 2008;69 :831-44.
31. DuRant EM, Leslie NS, Critch EA. Managing polycystic ovary syndrome: a cognitive behavioral strategy. Nurs Womens Health 2009;13:292-300.
32. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
33. The World Health Organization Quality of Life
assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41:1403-9.
34. Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The world health organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the whoqol group. Qual Life Res 2004;13:299-310.
35. Moradi A, Malekpour M, Amiri Sh, Molavi H, Nouri A. The comparison of the effects of self-esteem, self-efficacy and achievement motivation trainings on the quality of life in women with physical-motor disabilities. Research on exceptional children 2010;10:49-64.
36. Benetti-Pinto CL, Ferreira SR, Antunes A Jr, Yela DA. The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome. Arch Gynecol Obstet 2015;291:451-5.
37. Miller GE, Chen E, Parker KJ. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull 2011; 137: 959-97.
38. O'Donovan A, Slavich GM, Epel ES, Neylan TC. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev 2013; 37: 96-108.
39. Rosen JC. Body image disorder: Definition, development, and contribution to eating disorders. The etiology of bulimia nervosa: The individual and familial context 2013;1:157-77.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.